FERROPORTIN INHIBITORS AND METHODS OF USE

The subject matter described herein is directed to Ferroportin inhibitor compounds of Formula I and pharmaceutical salts thereof, methods of preparing the compounds, pharmaceutical compositions comprising the compounds and methods of administering the compounds for prophylaxis and/or treatment of di...

Full description

Saved in:
Bibliographic Details
Main Authors RADEMACHER, Peter Michael, ALT, Carsten, XU, Qing, YEE, Calvin Wesley, LI, Zhe, METCALF, Brian Walter
Format Patent
LanguageEnglish
French
Published 18.06.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The subject matter described herein is directed to Ferroportin inhibitor compounds of Formula I and pharmaceutical salts thereof, methods of preparing the compounds, pharmaceutical compositions comprising the compounds and methods of administering the compounds for prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, particularly iron overload states, such as thalassemia, sickle cell disease and hemochromatosis. L'invention concerne des composés inhibiteurs de ferroportine de formule I et des sels pharmaceutiques de ceux-ci, des procédés de préparation des composés, des compositions pharmaceutiques comprenant les composés et des procédés d'administration des composés pour la prophylaxie et/ou le traitement de maladies provoquées par un manque d'hepcidine ou des troubles du métabolisme du fer, en particulier des états de surcharge en fer, tels que la thalassémie, la drépanocytose et l'hémochromatose.
AbstractList The subject matter described herein is directed to Ferroportin inhibitor compounds of Formula I and pharmaceutical salts thereof, methods of preparing the compounds, pharmaceutical compositions comprising the compounds and methods of administering the compounds for prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, particularly iron overload states, such as thalassemia, sickle cell disease and hemochromatosis. L'invention concerne des composés inhibiteurs de ferroportine de formule I et des sels pharmaceutiques de ceux-ci, des procédés de préparation des composés, des compositions pharmaceutiques comprenant les composés et des procédés d'administration des composés pour la prophylaxie et/ou le traitement de maladies provoquées par un manque d'hepcidine ou des troubles du métabolisme du fer, en particulier des états de surcharge en fer, tels que la thalassémie, la drépanocytose et l'hémochromatose.
Author LI, Zhe
YEE, Calvin Wesley
ALT, Carsten
XU, Qing
RADEMACHER, Peter Michael
METCALF, Brian Walter
Author_xml – fullname: RADEMACHER, Peter Michael
– fullname: ALT, Carsten
– fullname: XU, Qing
– fullname: YEE, Calvin Wesley
– fullname: LI, Zhe
– fullname: METCALF, Brian Walter
BookMark eNrjYmDJy89L5WTQdHMNCvIP8A8K8fRT8PTz8HTyDPEPClZw9HNR8HUN8fB3CVbwd1MIDXblYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBkYGhkbGFqYGjobGxKkCALxlJwo
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate INHIBITEURS DE FERROPORTINE ET PROCÉDÉS D'UTILISATION
ExternalDocumentID WO2020123850A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2020123850A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:44:00 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2020123850A13
Notes Application Number: WO2019US66053
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200618&DB=EPODOC&CC=WO&NR=2020123850A1
ParticipantIDs epo_espacenet_WO2020123850A1
PublicationCentury 2000
PublicationDate 20200618
PublicationDateYYYYMMDD 2020-06-18
PublicationDate_xml – month: 06
  year: 2020
  text: 20200618
  day: 18
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies GLOBAL BLOOD THERAPEUTICS, INC
RelatedCompanies_xml – name: GLOBAL BLOOD THERAPEUTICS, INC
Score 3.2679894
Snippet The subject matter described herein is directed to Ferroportin inhibitor compounds of Formula I and pharmaceutical salts thereof, methods of preparing the...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title FERROPORTIN INHIBITORS AND METHODS OF USE
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200618&DB=EPODOC&locale=&CC=WO&NR=2020123850A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKeqbTsXLlIBS8KHYrveHIeuNVmhT2k73NtougiBzuIp_35PQ6Z72EnKBkxtfTr7knATgnjXMUJTGkFWcU1nngaO-mbJVOY1ZmQ2CkDsnJ6kZTfXnmTHrwcfGF0a8E_ojHkdERDWI91as16v_Qyxf2FauH-t3zPp8CsuxL3XsmPNjhLPvjoOM-tSTPA95m5TmogwXadtQJsiV9nAjbXEDsODF5X4pq22lEh7Dfobylu0J9NhyAIfe5u-1ARwk3ZU3Rjv0rU_hIQzynGY0L-OUxGkUu3FJ84JMUp8kQRlRvyA0JNMiOIO7MCi9SMY6539dnL_S7QZq59BH8s8ugNRG5VQ4apppM31U65hYaDZGDGaxUdVcwnCXpKvdxddwxJPc9Em1h9Bvv77ZDSrZtr4VY_MLG5N7WA
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bT4MwFD5ZpnG-6dR4mUqiIfGBCOMyeFjMoBDQQQkw3RsBrImJmYvD-Pc9JUz3tJem7Ul6zdf2a885BbhlFdNludIlBedU0nhgKW-GNCqsyiiMCkHIjZPDyPBn2uNcn3fgY20L0_gJ_WmcIyKiKsR73azXy_9LLNLoVq7uy3fM-nzwsjERW3bM-THCmdhjN6aEOqLjIG8To6SR4SJt6vIEudIOHrJN7mnffba5Xcpyc1PxDmA3xvIW9SF02KIPPWf991of9sL2yRujLfpWR3DnuUlCY5pkQSQEkR_YQUaTVJhERAjdzKckFagnzFL3GG48N3N8CevM_7qYv9DNBqon0EXyz05BKPXCKnDUVMNk2rDUMPGqmhjR2YgNi-oMBttKOt8uvoaen4XTfBpETxewz0VcDUoxB9Ctv77ZJW64dXnVjNMvC-d-SA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=FERROPORTIN+INHIBITORS+AND+METHODS+OF+USE&rft.inventor=RADEMACHER%2C+Peter+Michael&rft.inventor=ALT%2C+Carsten&rft.inventor=XU%2C+Qing&rft.inventor=YEE%2C+Calvin+Wesley&rft.inventor=LI%2C+Zhe&rft.inventor=METCALF%2C+Brian+Walter&rft.date=2020-06-18&rft.externalDBID=A1&rft.externalDocID=WO2020123850A1